Thyroid-Associated Ophthalmopathy

Explore clinical trials studying Thyroid-Associated Ophthalmopathy. Study availability and eligibility vary by location and protocol.

9 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Thyroid-Associated Ophthalmopathy trial results

Recruiting

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

NCT04936854

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Department of Ophthalmology Haukeland University Hospital Bergen, Hordaland, Norway

View Trial Details

Recruiting

A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy

NCT06927375

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Establishment of Multimodal-multiparametric Progressive Prediction Models for Thyroid Associated Ophthalmopathy

NCT06585592

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

NCT01868997

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations: Jules Stein Eye Institute at UCLA Los Angeles, California, United States

University of Denver Aurora, Colorado, United States

Emory University Department of Ophthalmology Atlanta, Georgia, United States

University of Iowa Hospitals and Clinics, Department of Ophthalmology Iowa City, Iowa, United States

View all 15 locations

View Trial Details

Completed

New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression

NCT02693808

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Department of Ophthalmology Haukeland University Hospital Bergen, Hordaland, Norway

View Trial Details

Completed

The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy

NCT01579539

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dry Eye Syndrome, +15 more
Locations: Department of Clinical Pharmacology, Medical University of Vienna Vienna, Austria

View Trial Details

Completed

99Tc-MDP for Thyroid-Associated Ophthalmopathy

NCT03948191

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Affiliated Zhongshan Hospital of Dalian University Dalian, Liaoning, China

View Trial Details

Completed

Trial of Rituximab for Graves' Ophthalmopathy

NCT00595335

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections

NCT01599273

Conditions: Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations: Severance hospital Seoul, South Korea

View Trial Details

Thyroid-Associated Ophthalmopathy

Thyroid-Associated Ophthalmopathy trial results

Related conditions